NANOVIRICIDES, INC. Debt Instrument, Interest Rate, Stated Percentage
NANOVIRICIDES, INC. (NNVC) had Debt Instrument, Interest Rate, Stated Percentage of 4.74% as of 2022-01-01, per its 10-K filed 2023-10-13.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateStatedPercentage · last filed 2023-10-13
- 2022-01-01: Debt Instrument, Interest Rate, Stated Percentage 4.74%.
- 2021-01-01: Debt Instrument, Interest Rate, Stated Percentage 4.74%.
- 2020-01-01: Debt Instrument, Interest Rate, Stated Percentage 5.00%.
- 2014-07-02: Debt Instrument, Interest Rate, Stated Percentage 10.00%.
| Period end | Debt Instrument, Interest Rate, Stated Percentage |
|---|---|
| 2022-01-01 | 4.74% 10-K · filed 2023-10-13 |
| 2021-01-01 | 4.74% 10-Q · filed 2023-05-15 |
| 2020-01-01 | 5.00% 10-Q · filed 2022-02-14 |
| 2014-07-02 | 10.00% 10-K · filed 2020-10-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |